Rapidly screening of pancreatic lipase inhibitors from Sibiraea angustata (rehd.) Hand.-Mazz. leaves using affinity ultrafiltration combined with HPLC-QTOFMS, molecular docking, targeted separation, and in vitro experimental verification
Hai Song,
No information about this author
Yangfei Wei,
No information about this author
Zhixiang Gu
No information about this author
et al.
Natural Product Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 8
Published: Jan. 24, 2025
An
integrated
strategy
was
proposed
for
the
rapid
screening
of
pancreatic
lipase
inhibitors
from
Sibiraea
angustata
(Rehd.)
Hand.-Mazz.
(S.
angustata)
leaves
based
on
affinity
ultrafiltration,
high-performance
liquid
chromatography-quadrupole
time-of-flight
mass
spectrometry
(HPLC-QTOFMS),
molecular
docking,
targeted
separation
and
in
vitro
experimental
verification.
A
total
fifteen
target
compounds,
including
five
flavonoids,
one
phenylpropanol
glycoside
nine
terpenoids,
had
been
screened
as
ethyl
acetate
n-butanol
fractions
S.
leaves.
Among
these
thirteen
them
are
reported
first
time.
Hyperin,
quercetin-3,4′-diglucoside
peltatoside
showed
stronger
binding
abilities
with
ΔG
values
−9.9,
−10.2
−9.2
kcal/mol
while
IC50
were
0.987
±
0.079,
0.718
0.054
0.916
0.069
mmol/L,
respectively.
The
compounds
separated
purities
higher
than
98%
using
macroporous
resin
preparative
chromatography.
Language: Английский
Rapid processing of liquid chromatography mass spectrometry data for compound screening and characterization in complex matrix based on Python: with Meconopsis quintuplinervia Regel as an example
Jiahao Yang,
No information about this author
Xialin Zhu,
No information about this author
Le Li
No information about this author
et al.
Journal of Chromatography A,
Journal Year:
2025,
Volume and Issue:
1753, P. 466022 - 466022
Published: May 5, 2025
Language: Английский
Comprehensive Investigation of Sweroside Metabolism in Rats Using a De Novo Strategy Based on Ultra‐High‐Performance Liquid Chromatography/Quadrupole‐Exactive Mass Spectrometry
Xuelin Sun,
No information about this author
Zhanpeng Shang,
No information about this author
Yatong Zhang
No information about this author
et al.
Journal of Separation Science,
Journal Year:
2024,
Volume and Issue:
47(23)
Published: Dec. 1, 2024
ABSTRACT
Sweroside,
a
natural
secoiridoid
glycoside
derived
from
various
medicinal
plants,
is
known
for
its
anti‐tumor,
anti‐inflammatory,
and
hepatoprotective
properties.
However,
pharmacological
significance
not
fully
supported
by
low
systemic
exposure.
In
this
study,
de
novo
strategy
was
proposed
to
investigate
the
metabolism
of
sweroside
in
rats,
including
drug
administration,
sample
pretreatment,
ultra‐high‐performance
liquid
chromatography/Quadrupole‐Exactive
mass
spectrometry
data
acquisition,
processing,
semi‐quantitative
analysis.
First,
following
oral
administration
plasma,
urine,
feces
were
collected,
respectively
mixed
using
area‐under‐the‐curve
pooling
method.
Secondly,
data‐dependent,
dynamic
exclusion,
parallel
reaction
monitoring
scan
modes
employed
build
tandem
spectra
database.
Using
neutral
loss
fragment‐based
method,
target
metabolites
effectively
filtered.
As
result,
demonstrated
be
extensively
metabolized,
while
18
identified
nine
them
newly
reported.
Sweroside
predominantly
underwent
phase
II
metabolism,
glycosylation,
sulfonation,
glucuronidation,
deglycosylation,
primarily
excreted
via
kidney.
Notably,
N
‐heterocyclization
(M7
M10)
likely
catalyzed
intestinal
bacteria.
This
study
only
elucidates
vivo
elimination
but
also
offers
an
efficient
approach
profiling
specific
molecules.
Language: Английский